TNF and rheumatoid arthritis: To directly assess the effect of current RA therapeutics on IR expression, we examined the impact of TNF Ab, GC, JAKi, and IL-6R Ab using adalimumab, prednisolone, tofacitinib, and tocilizumab, respectively.